CJC-1295 Benefits
Reviewed by Fat Man in the Arena · Updated March 2026
How CJC-1295 works
Mimics GHRH to stimulate pituitary GH release. The DAC (Drug Affinity Complex) version binds to albumin, extending its half-life to 6-8 days. The no-DAC version (mod GRF 1-29) has a shorter duration matching natural GH pulse patterns.
Reported benefits
Based on available research data, CJC-1295 has been associated with the following benefits:
- Sustained growth hormone elevation
- Improved body composition
- Enhanced recovery
- Better sleep quality
- Synergistic with GHRPs like ipamorelin
Supporting research
Prolonged stimulation of growth hormone secretion by CJC-1295
Journal of Clinical Endocrinology & Metabolism, 2006 · PMID: 16352683
CJC-1295 with DAC produced sustained 2-10 fold increases in GH and IGF-1 levels for 6+ days after a single injection in healthy adults.
Important context
Benefits reported in clinical trials represent average outcomes across study populations. Individual results vary based on genetics, dosage, duration, and lifestyle factors. This compound is not FDA-approved for human use. Benefits described are based on research data and should not be interpreted as therapeutic claims.
Related peptides
Weekly peptide research updates
New studies, GLP-1 news, protocol insights, and weight loss data — delivered every week. Free. No spam.